Pacific biosciences of california stock.
The company's average rating score is 2.73, and is based on 8 buy ratings, 3 hold ratings, and no sell ratings. Price Target Upside/Downside. According to ...
Pacific Biosciences of California Inc is up 8.17% from its previous closing price of $7.22. During the last market session, Pacific Biosciences of California Inc’s stock traded between $7.00 and $7.43. Currently, there are 255.00 million shares of Pacific Biosciences of California Inc stock available for purchase.Pacific Biosciences of California Non-GAAP EPS of -$0.35 beats by $0.02, revenue of $27.35M beats by $0.06M SA News Thu, Feb. 16 Pacific Biosciences of California Q4 2022 Earnings PreviewRaised approximately $201 million in gross proceeds in an upsized public offering of common stock in January 2023. ... Pacific Biosciences of California, Inc. Unaudited Condensed Consolidated Balance Sheets (in thousands) December 31, December 31, 2022. 2021. Assets. Cash and investments $ 772,318 $Pacific Biosciences of California Inc. PACB (U.S.: Nasdaq) Pacific Biosciences of California Inc. View All companies. AT CLOSE 1:00 PM EST 11/24/23. $8.55 USD.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems.Aug 2, 2023 · Pacific Biosciences (PACB) delivered earnings and revenue surprises of 23.53% and 17.95%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? Christian O. Henry. Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template ...
Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously announced underwritten public offering of 17,500,000 shares of its common stock ...
A steep rise in short interest was recorded in Pacific Biosciences of California Inc stocks on Oct 30, 2023, growing by 2.05 million shares to a total of 35.12 million shares. Yahoo Finance data shows the prior-month short interest on Sep 28, 2023 was 33.07 million shares. There was a rise of 5.84%, which implies that there is a …Management will host a quarterly conference call to discuss its first quarter ended March 31, 2022, results today at 5:00 p.m. Eastern Time. Investors may listen to the call by dialing 866-652-5200, or if outside the U.S., by dialing 412-317-6060, and request to join the “PacBio Q1 Earnings Call.”. The call will be webcast live and will be ... ٣٠/٠٨/٢٠٢٣ ... Pacific Biosciences of California (PacBio; PACB) shares have doubled year-over-year, zooming 101% despite a 26% decline earlier this month.٠٣/٠٤/٢٠٢١ ... Pacbio (Pacific Biosciences of California Inc) (Stock: PACB) CEO Christian Henry Interview on Business Outlook and Growth.A high-level overview of Pacific Biosciences of California, Inc. (PACB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Nov 26, 2023 · Pacific Biosciences of California Stock Up 2.3 %. Shares of NASDAQ:PACB opened at $8.55 on Friday. The company has a debt-to-equity ratio of 1.17, a current ratio of 4.80 and a quick ratio of 4.43.
Pacific Biosciences of California, Inc. ("PacBio") (NASDAQ: PACB) today announced that it has entered into a privately negotiated exchange agreement with a holder of PacBio's outstanding 1.50% ...
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists ...Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q4 2015 Results - Earnings Call Transcript SA Transcripts Wed, Feb. 03, 2016 Pacific Biosciences of California (PACB) Q4 2015 ...Pacific Biosciences of California, Inc. Common Stock (PACB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. According to 6 analyst offering 12-month price targets in the last 3 months, Pacific Biosciences has an average price target of $14.67 with a high of $17.00 and a low of $12.00. Below is a summary ...Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing.(RTTNews) - Pacific Biosciences of California, Inc. (PACB) reported Loss for second quarter that decreased from the same period last year and beat the Street estimates. The company's bottom line ...Overview News Pacific Biosciences of California Inc. No significant news for in the past two years. Shares Sold Short 35.12 M Change from Last -6.95% Percent of Float 13.74% …
PacBio highly accurate long-read sequencing provides the most comprehensive view of genomes, transcriptomes, and epigenomes. Learn how SMRT sequencing powers genomic insights in humans, plants, animals and microbes.Oct 30, 2023 · Oct. 30, 2023, 04:07 PM. (RTTNews) - Pacific Biosciences of California, Inc. (PACB) released Loss for third quarter that decreased from the same period last year and beat the Street estimates. The ... Pacific Biosciences of California's CEO is Christian O. Henry, appointed in Sep 2020, has a tenure of 3.17 years. total yearly compensation is $6.62M, comprised of 10.1% salary and 89.9% bonuses, including company stock and options. directly owns 0.088% of the company’s shares, worth $2.03M.Industry Rank: Top 29% (74 out of 251) Industry: Medical - Instruments. Pacific Biosciences of California (PACB) Quote Overview » More Research » Pacific Biosciences of California (PACB ...Common Stock, par value $0.001 per share. PACB. ... Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The Company has developed Single Molecule, …Pacific Biosciences of California Stock Forecast and Price Target. Year-long price target forecasts from four prominent analysts have recently been released for Pacific Biosciences of California, with an average price target of $10.50. This potential gain of 24.41 percent from the previous closing price in November, 2023 is calculated on …Of course Pacific Biosciences of California may not be the best stock to buy.So you may wish to see this free collection of growth stocks.. Please note, the market returns quoted in this article ...
The notes will have a conversion price of $43.50 per share of the company's common stock, representing a 10% premium over Pacific Biosciences' share price as of the end of yesterday's trading session.Pacific Biosciences of California Inc’s ( PACB) price is currently down 20.92% so far this month. During the month of February, Pacific Biosciences of California Inc’s stock price has reached a high of $12.35 and a low of $8.71. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as …
Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis.Pacific Biosciences (PACB) delivered earnings and revenue surprises of 6.06% and 10.55%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing.Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. ... Stock Pacific Biosciences of California, Inc. - Nasdaq . News Pacific Biosciences of …Pacific Biosciences of California Stock Performance. Shares of NASDAQ PACB opened at $8.88 on Friday. The business has a fifty day simple moving average of $7.76 and a 200 day simple moving ...٢٠/١١/٢٠٢٣ ... PACB has a roughly average overall score of 41 meaning the stock holds a better value than 41% of stocks at its current price.
Dec 2, 2023 · Pacific Biosciences of California Stock Forecast 11-26-2023. Forecast target price for 11-26-2023: $ 8.02. Negative dynamics for Pacific Biosciences of California shares will prevail with possible volatility of 5.469%. Pessimistic target level: 7.80.
Pacific Biosciences of California Stock Up 2.3 %. Shares of NASDAQ:PACB opened at $8.55 on Friday. The company has a debt-to-equity ratio of 1.17, a current ratio of 4.80 and a quick ratio of 4.43.
Get the latest news and real-time alerts from Pacific Biosciences of California, Inc. (PACB) stock at Seeking Alpha.Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously announced underwritten public offering of 17,500,000 shares of its common stock ...California is located on the West Coast of the United States. California is bordered by Oregon in the north, Nevada to the east, Arizona to the southeast, Mexico’s Baja California to the southeast and the Pacific Ocean to the west.Raised approximately $201 million in gross proceeds in an upsized public offering of common stock in January 2023. ... Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve …The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California analysts is $. Today ...Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously announced underwritten public offering of 17,500,000 shares of its common stock ...Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists ...Jan 9, 2023 · Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists ... PacBio highly accurate long-read sequencing provides the most comprehensive view of genomes, transcriptomes, and epigenomes. Learn how SMRT sequencing powers genomic insights in humans, plants, animals and microbes.Nov 29, 2023 · See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Oct. 30, 2023, 04:07 PM. (RTTNews) - Pacific Biosciences of California, Inc. (PACB) released Loss for third quarter that decreased from the same period last year and beat the Street estimates. The ...Pacific Biosciences of California Inc’s ( PACB) price is currently down 18.93% so far this month. During the month of August, Pacific Biosciences of California Inc’s stock price has reached a high of $13.36 and a low of $10.67. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.55 and as low as …
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists ...Discover Pacific Biosciences of California's earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. ... Independent Director exercised options and sold US$793k worth of stock May 29. The Pullback In Pacific Biosciences Makes For A Much More Interesting Opportunity …STOCK INFORMATION IRS Notification Form 8937 Omniome Stock Quote Change Volume Today's Open Previous Close Today's High Today's Low 52 Week High 52 …A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its trailing twelve months earnings. ... Pacific Biosciences of California rises after UBS upgrades on strong 'Revio ...Instagram:https://instagram. mac donald share pricedow price targetbest prefered stock etfprecious metals stock The Pacific Biosciences of California stock prediction for 2025 is currently $ 21.57, assuming that Pacific Biosciences of California shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 157.52% increase in the PACB stock price. mlpdx stock pricebest vanguard bond Pacific Biosciences of California Inc’s ( PACB) price is currently down 20.92% so far this month. During the month of February, Pacific Biosciences of California Inc’s stock price has reached a high of $12.35 and a low of $8.71. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as … financial advising software Aug 2, 2023 · Pacific Biosciences (PACB) delivered earnings and revenue surprises of 23.53% and 17.95%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? As of February 15, 2023, 4:00 PM CST, Pacific Biosciences of California Inc’s stock price was $11.09. Pacific Biosciences of California Inc is up 7.88% from its previous closing price of $10.28. During the last market session, Pacific Biosciences of California Inc’s stock traded between $9.75 and $10.47.Nov 30, 2023 · PacBio highly accurate long-read sequencing provides the most comprehensive view of genomes, transcriptomes, and epigenomes. Learn how SMRT sequencing powers genomic insights in humans, plants, animals and microbes.